Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Dumusc

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Revue Medicale Suisse|April 8, 2014
[Complications and systemic manifestations of rheumatoid arthritis]A Dumusc, A So
Revue Medicale Suisse|May 8, 2015
[Elbow tendinopathy]A Dumusc, P Zufferey
Hand Surgery & Rehabilitation|September 10, 2022
Anakinra treatment of acute calcium deposits in hand and wristA Durdzińska Timóteo, A Dumusc, S Durand
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 16, 2018
ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Soluble immune effector molecules [II]: agents targeting interleukins, immunoglobulins and complement factors)K L Winthrop, X Mariette, J T Silva, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Revue Medicale Suisse|April 8, 2014
[Complications and systemic manifestations of rheumatoid arthritis]A Dumusc, A So
Revue Medicale Suisse|May 8, 2015
[Elbow tendinopathy]A Dumusc, P Zufferey
Hand Surgery & Rehabilitation|September 10, 2022
Anakinra treatment of acute calcium deposits in hand and wristA Durdzińska Timóteo, A Dumusc, S Durand
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 16, 2018
ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Soluble immune effector molecules [II]: agents targeting interleukins, immunoglobulins and complement factors)K L Winthrop, X Mariette, J T Silva, et al.
Pageof 1